Kiniksa Pharmaceuticals International
KNSA
77.96
+0.87
+1.13%
Kiniksa Pharmaceuticals International
US · KNSA
#1938 by market cap
Listed 2018
77.96
+0.87
+1.13%
Live - 5344 symbols - heartbeat 418s ago
· 2026-10-07 19:54
After-hours
78.50
+0.69%
- Market cap
- 6.08B
- P/E (TTM)i
- 78.75
- P/Bi
- 9.30
- EPSi
- 0.75
- Div yieldi
- 0.00%
- 52W posi
- 90%
Reader sentiment
Are you bullish or bearish on KNSA?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 7 analysts
Buy
Avg price target
96.57 +23.9%
Price target rangecurrent 77.96
Low87.00
Avg96.57
High107.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-29 | Wells Fargo | -- | BUY | 87.00 |
| 2026-08-12 | CCORF | -- | BUY | 98.00 |
| 2026-07-30 | Goldman Sachs | -- | BUY | 90.00 |
| 2026-07-29 | CCORF | -- | BUY | 98.00 |
| 2026-07-29 | Citi | -- | BUY | 100.00 |
| 2026-07-29 | J.P. Morgan | -- | BUY | 107.00 |
| 2026-07-28 | TD Cowen | -- | BUY | 95.00 |
| 2026-07-28 | Wedbush | -- | BUY | 99.00 |
| 2026-07-23 | Goldman Sachs | -- | BUY | 75.00 |
| 2026-06-29 | Wedbush | -- | BUY | 72.00 |
| 2026-05-04 | J.P. Morgan | -- | BUY | 72.00 |
| 2026-04-29 | CCORF | -- | BUY | 64.00 |
| 2026-04-29 | Wells Fargo | -- | BUY | 57.00 |
| 2026-04-29 | Wedbush | -- | BUY | 59.00 |
| 2026-04-29 | Citi | -- | BUY | 60.00 |
| 2026-04-28 | TD Cowen | -- | BUY | 65.00 |
| 2026-04-28 | Jefferies | -- | BUY | 71.00 |
| 2026-04-16 | Wedbush | -- | BUY | 58.00 |
| 2026-04-14 | Wells Fargo | -- | BUY | 53.00 |
| 2026-03-13 | J.P. Morgan | -- | BUY | 68.00 |
| 2026-02-26 | CCORF | -- | BUY | 62.00 |
| 2026-02-24 | TD Cowen | -- | BUY | 60.00 |
| 2026-02-24 | Wedbush | -- | BUY | 53.00 |
| 2026-02-19 | CCORF | -- | BUY | 62.00 |
| 2026-01-30 | Citi | -- | BUY | 50.00 |
Quant vs Street three independent views, side by side
Momentum strategy signal
Buy
Analyst consensus
Buy
All 2 views agree: bullish.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-07-28 | -- | ±10.43% | +25.03% (beat) |
| 2026/Q1 | 2026-04-28 | -- | ±14.50% | +23.48% (beat) |
| 2025/Q4 | 2026-02-24 | -- | ±16.08% | -8.21% (in line) |
| 2025/Q3 | 2025-10-28 | -- | ±13.44% | -2.88% (in line) |
| 2025/Q2 | 2025-07-29 | -- | ±13.46% | +12.32% (in line) |
| 2025/Q1 | 2025-04-29 | -- | ±14.08% | +20.54% (beat) |
| 2024/Q4 | 2025-02-25 | -- | ±15.15% | +0.46% (in line) |
| 2024/Q3 | 2024-10-29 | -- | ±15.18% | -15.68% (beat) |
| 2024/Q2 | 2024-07-23 | -- | ±9.98% | +22.91% (beat) |
| 2024/Q1 | 2024-04-23 | -- | ±15.53% | +3.42% (in line) |
| 2023/Q4 | 2024-02-28 | -- | ±16.65% | -2.54% (in line) |
| 2023/Q3 | 2023-10-31 | -- | ±15.18% | -2.74% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.